Portal Hypertension in a Case of Klippel Trenaunay Syndrome.
作者信息
Sait Haseena, Sahi Puneet Kaur, Kapoor Seema
机构信息
Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.
出版信息
Indian Pediatr. 2020 Aug 15;57(8):754-755. doi: 10.1007/s13312-020-1925-4.
Abstract
摘要
相似文献
1
Portal Hypertension in a Case of Klippel Trenaunay Syndrome.克-特综合征（Klippel Trenaunay Syndrome）一例中的门静脉高压
Indian Pediatr. 2020 Aug 15;57(8):754-755. doi: 10.1007/s13312-020-1925-4.
2
Klippel-Trenaunay syndrome with anorectum involvement and portal hypertension.
Pediatr Int. 2022 Jan;64(1):e15165. doi: 10.1111/ped.15165.
3
Klippel-Trenaunay syndrome with gastrointestinal involvement and portal hypertension-evaluation and management.伴有胃肠道受累及门静脉高压的克-特综合征——评估与管理
Dig Liver Dis. 2022 Oct;54(10):1455-1457. doi: 10.1016/j.dld.2022.04.005. Epub 2022 May 5.
4
[A case of Klippel-Trenaunay-Weber syndrome presenting with esophageal and gastric varices bleeding].[1例以食管和胃静脉曲张出血为表现的克-特-韦综合征]
Korean J Gastroenterol. 2004 Feb;43(2):137-41.
5
Prehepatic portal hypertension of a vascular origin: Klippel-Trenaunay syndrome.肝前性门静脉高压的血管源性病因：克莱彭特伦纳尹综合征。
Rev Esp Enferm Dig. 2019 Dec;111(12):979. doi: 10.17235/reed.2019.6597/2019.
6
Klippel-Trenaunay-Weber syndrome with visceral involvement and portal hypertension.伴有内脏受累及门静脉高压的克-特-韦综合征
Cleve Clin Q. 1982 Winter;49(4):239-47. doi: 10.3949/ccjm.49.4.239.
7
Klippel-Trenaunay syndrome: a case study.克-特综合征：一项病例研究。
Adv Neonatal Care. 2009 Jun;9(3):120-4. doi: 10.1097/ANC.0b013e3181a68b15.
8
An infantile case of Sturge-Weber syndrome in association with Klippel-Trenaunay-Weber syndrome and phakomatosis pigmentovascularis.一例合并克-特-韦综合征及色素血管性斑痣性错构瘤病的婴儿期斯特奇-韦伯综合征病例。
J Korean Med Sci. 2005 Dec;20(6):1082-4. doi: 10.3346/jkms.2005.20.6.1082.
9
Klippel-Trenaunay-Weber syndrome with hemimegalencephaly. Report of a case.伴有半侧巨脑症的克-特-韦综合征。病例报告。
Turk J Pediatr. 1996 Apr-Jun;38(2):277-80.
10
Klippel-Trénaunay syndrome: 2 case reports and a review of genitourinary manifestations.克-特综合征：2例报告及泌尿生殖系统表现综述
J Urol. 2001 Oct;166(4):1418-20. doi: 10.1016/s0022-5347(05)65798-9.
本文引用的文献
1
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.西罗莫司治疗广泛和/或复杂慢血流血管畸形有效：单中心前瞻性 II 期研究。
Orphanet J Rare Dis. 2018 Oct 29;13(1):191. doi: 10.1186/s13023-018-0934-z.
2
PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.PI3K/mTOR 抑制促进由 PIK3CA 激活突变驱动的实验性血管畸形的消退。
Cell Death Dis. 2018 Jan 19;9(2):45. doi: 10.1038/s41419-017-0064-x.
3
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.淋巴管及其他血管畸形/过度生长疾病由PIK3CA基因的体细胞突变引起。
J Pediatr. 2015 Apr;166(4):1048-54.e1-5. doi: 10.1016/j.jpeds.2014.12.069. Epub 2015 Feb 11.
4
Portomesenteric venous thrombosis associated with rectal venous malformations.与直肠静脉畸形相关的肠系膜静脉血栓形成。
J Pediatr Surg. 2010 Jun;45(6):1221-7. doi: 10.1016/j.jpedsurg.2010.02.092.
5
Klippel-Trénaunay syndrome: spectrum and management.克-特综合征：范围及处理
Mayo Clin Proc. 1998 Jan;73(1):28-36. doi: 10.1016/S0025-6196(11)63615-X.
Zotero 插件